Healthcare Contract Research Organization Industry Overview

The global healthcare contract research organization (CRO) market size was valued at USD 50.55 billion in 2023 and is anticipated to grow at a CAGR of 7.0% from 2024 to 2030. 

Increasing investment in R&D programs, preference for outsourcing activities due to time & cost constraints, and patent expiration of blockbuster drugs are key factors anticipated to drive the market in the coming years. Contract research organization (CRO) collaborations offer advanced services, and thus pharmaceutical and biopharmaceutical companies mostly prefer assigning projects to CROs, facilitating market growth.

Increasing pressure on drug developers pertaining to clinical data management, regulatory environments, and stringent safety standards are expected to drive demand for contract research organizations within a healthcare sector. Healthcare and pharmaceutical companies are outsourcing the production of medicines and their clinical trials. With increasing clinical trial privatization, there is a surge in outsourcing to developing countries. Many healthcare contract research organizations (CRO) are enhancing their global research network to provide better customer services.

Gather more insights about the market drivers, restrains and growth of the Healthcare Contract Research Organization Market

For instance, in February 2023, MMS, a CRO specializing in data, announced a collaboration with the Institute for Advanced Clinical Trials (I-ACT) to expedite advancement of critical therapeutics such as medications, vaccines, and medical devices specifically tailored for pediatric use. As part of its commitment, MMS is sponsoring I-ACT's Spin Challenge, a unique initiative to generate funds to propel and hasten clinical trials focused on children's healthcare.

The outbreak of the COVID-19 pandemic has significantly hampered the growth of the healthcare CRO industry. Factors such as a shortage of patients and temporary closure of clinical trial operating sites have negatively impacted the market. However, this crisis created a need for virtual trials, thereby leveraging usage of digital technology & software solutions. Increasing adoption of machine learning-based platforms, artificial intelligence, and innovative trial designs has helped the industry mitigate the pandemic’s negative impact, thereby witnessing a revenue rebound.

However, 2020 to 2022 was a challenging period for international business, reflecting escalating geopolitical tensions, tighter monetary policy, high inflation, ongoing pandemic, and looming recessions. The global supply chain witnessed significant risks of bifurcation in 2022 as the Ukraine-Russia conflict became a new geopolitical fault line and China-U.S. tensions remained high. Hence, the market has witnessed comparatively sluggish growth from 2020 to 2022.

Pharmaceutical industry also witnessed a backlash across its annual growth due to high inflation and decreasing FDA approval in 2022 and 2023. Pharmaceutical and biopharmaceutical companies tend to outsource the development process of New Molecular Entities (NME). However, a considerable decline in the rate of NME approvals was witnessed in 2022. This also implies that a decline in NME approvals shall directly decrease a commercial scale production agreement for larger contact researchers and manufacturers. 

Browse through Grand View Research's  Medical Devices Industry Research Reports.

• The global clinical trials market size was valued at USD 80.7 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.49% from 2024 to 2030.
• The global CRO market is expected to witness sustainable growth (CAGR of 6.4%) from 2020 to 2025 due to the increasing global need for drug development and investments by pharma giants in R&D, owing to the patent expiration of blockbuster drugs.

Healthcare Contract Research Organization Market Segmentation

Grand View Research has segmented the global healthcare contract research organization market on the basis of type, services, and region:

Healthcare Contract Research Organization Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Drug Discovery
• Pre-clinical
• Clinical

Healthcare Contract Research Organization Services Outlook (Revenue, USD Billion, 2018 - 2030)

• Project Management/Clinical Supply Management
• Data Management
• Regulatory/Medical Affairs
• Medical Writing
• Clinical Monitoring
• Quality Management/ Assurance
• Bio-statistics
• Investigator Payments
• Laboratory
• Patient And Site Recruitment
• Technology
• Others

Healthcare Contract Research Organization Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America
  1. U.S.
  2. Canada
• Europe
  1. U.K.
  2. Germany
  3. France
  4. Italy
  5. Spain
  6. Sweden
  7. Norway
  8. Denmark
  9. Switzerland
  10. Belgium
  11. Netherlands
  12. Austria
• Asia Pacific
  1. Japan
  2. China
  3. India
  4. South Korea
  5. Australia
  6. Thailand
  7. Taiwan
  8. Indonesia
  9. Malaysia
  10. Singapore
• Latin America
  1. Brazil
  2. Mexico
  3. Argentina
  4. Colombia
  5. Chile
• Middle East & Africa
  1. South Africa
  2. Saudi Arabia
  3. UAE
  4. Kuwait
  5. Egypt
  6. Iran
  7. Israel

Key Companies profiled:

• ICON Plc
• Charles River Laboratories
• Syneos Health
• IQVIA Inc.
• GVK Biosciences Private Limited
• Laboratory Corporation of America Holdings
• Thermo Fisher Scientific Inc.
• Parexel International Corporation
• Medidata Solutions, Inc.
• Pharmaron GMBH
• SGS SA
• KCR S.A.
• CTI Clinical Trial & Consulting
• PSI
• Worldwide Clinical Trials
• Wuxi AppTec
• Advanced Clinical
• Pharm-Olam, LLC
• Caidy

Key Healthcare Contract Research Organization Company Insights

The competition in the healthcare Contract Research Organization (CRO) market is intense, driven by an increasing demand for outsourcing clinical trial services globally. CRO healthcare companies are vying for market share through strategic collaborations, acquisitions, and technological advancements to enhance their service offerings and expand geographic reach. The market is characterized by a diverse range of CRO healthcare companies, varying in size and specialization, catering to pharmaceutical, biotechnology, and medical device companies. With a focus on providing end-to-end solutions, CROs are continuously innovating to streamline the drug development process, improve efficiency, and deliver high-quality outcomes, ultimately positioning themselves competitively in the dynamic healthcare CRO landscape.

Recent Developments

• In May 2023, Charles River Laboratories International, Inc. and Wheeler Bio, Inc. agreed to introduce RightSourceSM at Wheeler Bio's manufacturing facility in Oklahoma City. RightSource, situated at a client location, represents a versatile biologics testing laboratory overseen and supervised by Charles River. This initiative aims to enhance the accessibility of swift, dependable quality control services to a more extensive spectrum of companies.
• In January 2023, Bruker Corporation and Switzerland-based biopharma CRO Biognosys AG announced a strategic partnership for biologics-based clinical research. This partnership helped Biognosys AG plan to open its first laboratory for advanced proteomics outsourcing services in the U.S.

Order a free sample PDF of the Healthcare Contract Research Organization Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter